Delivery Order SPE2DB20D3101-SPE2DB24FRJV4

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB22D3016|SPE2DB24FADH5, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,280.64 Firm Fixed Price contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a medical product, with a period of performance through November 16, 2023. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTZC2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a $1,025.18 firm-fixed-price delivery order for the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has a January 16, 2025 completion date and was awarded on January 15, 2025. AmerisourceBergen Drug Corp is the prime contractor and is a major pharmaceutical distributor and healthcare solutions provider. This...
This federal contract award, valued at $1,340.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D2002|SPE2DB25FL19H) with a firm fixed price pricing type, and an ultimate completion date of February 13, 2025. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. This award is not designated as a set-aside...
This federal contract award, identified as SPE2DB20D3103|SPE2DB23FL7A8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,579.71 firm fixed-price delivery order is for the supply of 4559188508 - XULANE 150-35 MCG/DAY PATCH 3S, with a period of performance ending on November 28, 2022. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds...
This federal contract award, with ID SPE2DX15D1104|SPE2DX23F3PR1, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,505.59 firm fixed-price delivery order is for the medical product "XULANE 150-35 MCG/DAY PATCH 3S" and has a completion date of May 9, 2023. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a...
This federal contract award, with an ID of SPE2DB22D3009|SPE2DB24FBA74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,612.06, is a Delivery Order contract for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of July 18, 2024 and is a Firm Fixed Price arrangement. It is not designated as a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.67 delivery order contract is a Firm Fixed Price type with a completion date of September 22, 2023. The contract provides the DLA with the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S". This award does not have a set-aside designation, indicating open competition. Amerisourcebergen also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,302.18 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen is the prime contractor on this award and holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FFC71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $5,054.06, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 16, 2025. Amerisourcebergen Drug Corp, the prime...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAVZ9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,720.72 firm fixed-price delivery order covers the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a period of performance through May 20, 2024. The contract was not designated with a set-aside requirement, indicating open competition....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRJV4
    Delivery Order

This federal contract award, identified as SPE2DB20D3101|SPE2DB24FRJV4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,996.72, is a Firm Fixed Price Delivery Order for the supply of the medical product "XULANE 150-35 MCG/DAY PATCH 3S". The contract has a completion date of May 9, 2024.

Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization and a registered vendor in the System for Award Management (SAM.gov). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:12 PM